- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 2,508.7 | 2,490.68 |
| R2 | 2,551.8 | 2,514.02 |
| R3 | 2,607.6 | 2,551.8 |
| PP | 2,452.9 | 2,452.9 |
| S1 | 2,508.7 | 2,490.68 |
| S2 | 2,354 | 2,391.78 |
| S3 | 2,310.9 | 2,354 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 74.32 | - | 63.79 | - |
| ROE | - | 55.7 | - | 47.15 | - |
| EPS | 16.36 | 14.92 | 12.08 | 15.35 | 13.49 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924. The Company' s name was changed to Glaxo (India) Limited' from Glindia Limited in year 1987 and further to 'GlaxoSmithKline Pharmaceuticals Limited' from Glaxo (India) Limited effective from October 22, 2001.
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a ...
ISIN :INE159A01016
Registered Office
GSK House,Dr Annie Besant Road Worli
Contact number
+ 91-022-24959595
Registrars
KFin Techologies Ltd
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Contact number
+ 91-40-67162222
Management
Renu S Karnad (Chairman)
Bhushan Akshikar (Director)
Open IPO’s
FAQs
The share price of Glaxosmithkline Pharmaceuticals Ltd on the BSE is - as on -